Published in Curr Alzheimer Res on July 01, 2012
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58
Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals. J Infect Dis (2014) 1.74
An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease. Alzheimers Dement (2014) 1.26
Apolipoprotein E and change in episodic memory in blacks and whites. Neuroepidemiology (2013) 0.90
Cognitive aging in older Black and White persons. Psychol Aging (2015) 0.83
Temporal course and pathologic basis of unawareness of memory loss in dementia. Neurology (2015) 0.81
Depressive symptoms and cognitive decline in older african americans: two scales and their factors. Am J Geriatr Psychiatry (2014) 0.80
Longitudinal epidemiologic clinical-pathologic studies of aging and Alzheimer's disease. Curr Alzheimer Res (2012) 0.78
Self-Reported Sleep in Older African Americans and White Americans. Ethn Dis (2016) 0.75
Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology. Alzheimer Dis Assoc Disord (2016) 0.75
Motor Function Is Associated With Incident Disability in Older African Americans. J Gerontol A Biol Sci Med Sci (2015) 0.75
Loneliness in Older Black Adults with Human Immunodeficiency Virus Is Associated with Poorer Cognition. Gerontology (2017) 0.75
Transition Between the Timed up and Go Turn to Sit Subtasks: Is Timing Everything? J Am Med Dir Assoc (2016) 0.75
Establishing Composite Cognitive Endpoints for Use in Preclinical Alzheimer's Disease Trials. J Prev Alzheimers Dis (2015) 0.75
Perceived Stress and Cognitive Decline in Different Cognitive Domains in a Cohort of Older African Americans. Am J Geriatr Psychiatry (2016) 0.75
Examination of the Factor Structure of a Global Cognitive Function Battery across Race and Time. J Int Neuropsychol Soc (2015) 0.75
Change in motor function and adverse health outcomes in older African-Americans. Exp Gerontol (2015) 0.75
Change in Cognitive Abilities in Older Latinos. J Int Neuropsychol Soc (2015) 0.75
Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans. Alzheimers Dement (2016) 0.75
APOE ε4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans. PLoS One (2017) 0.75
Genetic structure of human populations. Science (2002) 30.91
Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health (1998) 9.58
Race, socioeconomic status, and health. The added effects of racism and discrimination. Ann N Y Acad Sci (1999) 8.79
The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA (1998) 7.81
Race and genomics. N Engl J Med (2003) 6.19
Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology (2001) 5.98
Painting a truer picture of US socioeconomic and racial/ethnic health inequalities: the Public Health Disparities Geocoding Project. Am J Public Health (2005) 5.38
Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res (2012) 4.91
Overview and findings from the religious orders study. Curr Alzheimer Res (2012) 3.46
Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol (2004) 3.39
Understanding disparities in donor behavior: race and gender differences in willingness to donate blood and cadaveric organs. Med Care (2002) 3.37
Factors influencing families' consent for donation of solid organs for transplantation. JAMA (2001) 3.35
Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology (1996) 3.29
Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA (2002) 3.16
Lessons learned about minority recruitment and retention from the Centers on Minority Aging and Health Promotion. Gerontologist (2003) 3.12
The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database. Alzheimer Dis Assoc Disord (2004) 2.97
Genetic variation, classification and 'race'. Nat Genet (2004) 2.63
Disentangling race and socioeconomic status: a key to understanding health inequalities. J Urban Health (2005) 2.55
Epigenetics and the embodiment of race: developmental origins of US racial disparities in cardiovascular health. Am J Hum Biol (2008) 2.52
Neurodegenerative basis of age-related cognitive decline. Neurology (2010) 2.41
Racism and cardiovascular disease in African Americans. Am J Med Sci (2003) 2.23
From the Centers for Disease Control and Prevention. Public health and aging: trends in aging--United States and worldwide. JAMA (2003) 2.12
Dementia and race: are there differences between African Americans and Caucasians? J Am Geriatr Soc (2001) 2.05
Purpose in life is associated with mortality among community-dwelling older persons. Psychosom Med (2009) 1.81
Disparities in cognitive functioning by race/ethnicity in the Baltimore Memory Study. Environ Health Perspect (2004) 1.77
Self-reported experiences of everyday discrimination are associated with elevated C-reactive protein levels in older African-American adults. Brain Behav Immun (2009) 1.75
Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience. J Clin Oncol (2005) 1.74
Understanding the challenges in recruiting blacks to a longitudinal cohort study: the Adventist health study. Ethn Dis (2004) 1.72
How race becomes biology: embodiment of social inequality. Am J Phys Anthropol (2009) 1.57
Recruitment strategies for minority participation: challenges and cost lessons from the POWER interview. Ethn Dis (2005) 1.52
Brain donation in normal aging: procedures, motivations, and donor characteristics from the Biologically Resilient Adults in Neurological Studies (BRAiNS) Project. Gerontologist (2001) 1.45
Life space and risk of Alzheimer disease, mild cognitive impairment, and cognitive decline in old age. Am J Geriatr Psychiatry (2011) 1.35
The effect of maintaining cognition on risk of disability and death. J Am Geriatr Soc (2010) 1.35
Diabetes and cognitive systems in older black and white persons. Alzheimer Dis Assoc Disord (2010) 1.34
Women who maintain optimal cognitive function into old age. J Am Geriatr Soc (2007) 1.31
Cognitive function is associated with the development of mobility impairments in community-dwelling elders. Am J Geriatr Psychiatry (2011) 1.20
Autopsy recruitment program for African Americans. Alzheimer Dis Assoc Disord (2001) 1.20
Explaining racial disparities in adverse birth outcomes: unique sources of stress for Black American women. Soc Sci Med (2011) 1.19
Barriers to minority participation in breast carcinoma prevention trials. Cancer (2005) 1.18
Ethnic differences in cognitive function over time. Ann Epidemiol (2009) 1.18
The neuropathology of Alzheimer disease in African American and white individuals. Arch Neurol (2006) 1.11
Perceptions, knowledge, incentives, and barriers of brain donation among African American elders enrolled in an Alzheimer's research program. Gerontologist (2010) 1.10
The prevalence of the neuropathological lesions of Alzheimer's disease is independent of race and gender. Neurobiol Aging (2001) 1.03
Racial differences in the association of education with physical and cognitive function in older blacks and whites. J Gerontol B Psychol Sci Soc Sci (2011) 1.03
Factors influencing decisions about donation of the brain for research purposes. Age Ageing (1998) 1.03
Moving beyond attitudinal barriers: understanding African Americans' support for organ and tissue donation. J Natl Med Assoc (2005) 1.01
The racial genetics paradox in biomedical research and public health. Public Health Rep (2002) 0.93
A descriptive study of neuritic plaques and neurofibrillary tangles in an autopsy population. Am J Epidemiol (1984) 0.90
Vascular and Alzheimer-type pathology in an autopsy study of African-Americans. Neurology (2006) 0.85
Racial differences in the etiology of dementia and frequency of Alzheimer lesions in the brain. J Natl Med Assoc (1989) 0.84
Culturally competent methods to promote organ donation rates among African-Americans using venues of the Bureau of Motor Vehicles. Transplant Proc (2008) 0.78
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol (2003) 14.87
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology (2007) 9.27
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol (2007) 8.10
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet (2009) 7.16
Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA (2011) 6.92
Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging (2002) 6.18
Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA (2002) 6.18
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol (2011) 6.00
Charting a dynamic DNA methylation landscape of the human genome. Nature (2013) 5.80
The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology (2005) 5.64
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol (2004) 5.11
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement (2012) 5.10
TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol (2007) 5.02
The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol (2009) 4.96
Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res (2012) 4.91
GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66
Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell (2013) 4.45
Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol (2003) 4.37
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol (2002) 3.84
Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell (2013) 3.83
Psychosocial distress and stroke risk in older adults. Stroke (2012) 3.83
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77
Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol (2014) 3.75
Early and late life cognitive activity and cognitive systems in old age. J Int Neuropsychol Soc (2005) 3.68
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. Lancet Neurol (2012) 3.66
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest (2012) 3.65
Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol (2003) 3.56
Overview and findings from the religious orders study. Curr Alzheimer Res (2012) 3.46
Loneliness and risk of Alzheimer disease. Arch Gen Psychiatry (2007) 3.44
Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol (2004) 3.39
The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study. Lancet Neurol (2006) 3.38
Design of the Chicago Health and Aging Project (CHAP). J Alzheimers Dis (2003) 3.36
Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA (2002) 3.19
Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology (2006) 3.00
Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron (2008) 2.99
Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol (2010) 2.91
White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging (2005) 2.79
Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol (2013) 2.78
Accounting for bias due to selective attrition: the example of smoking and cognitive decline. Epidemiology (2012) 2.72
Contribution of Alzheimer disease to mortality in the United States. Neurology (2014) 2.67
Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science (2011) 2.66
Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol (2007) 2.66
Microinfarct pathology, dementia, and cognitive systems. Stroke (2011) 2.61
Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology (2013) 2.59
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58
The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis (2009) 2.54
Nigral pathology and parkinsonian signs in elders without Parkinson disease. Ann Neurol (2012) 2.52
CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci (2013) 2.51
Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet (2010) 2.51
Olfactory identification and incidence of mild cognitive impairment in older age. Arch Gen Psychiatry (2007) 2.41
Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch Neurol (2005) 2.38
Cerebral microinfarcts: the invisible lesions. Lancet Neurol (2012) 2.31
Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly. Psychosom Med (2007) 2.27
Association between late-life social activity and motor decline in older adults. Arch Intern Med (2009) 2.26
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology (2012) 2.19
Substantia nigra tangles are related to gait impairment in older persons. Ann Neurol (2006) 2.17
A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology. Ann Neurol (2015) 2.16
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron (2013) 2.13
Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry (2005) 2.08
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Effect of a purpose in life on risk of incident Alzheimer disease and mild cognitive impairment in community-dwelling older persons. Arch Gen Psychiatry (2010) 2.07
Chronic psychological distress and risk of Alzheimer's disease in old age. Neuroepidemiology (2006) 2.07
Conscientiousness and the incidence of Alzheimer disease and mild cognitive impairment. Arch Gen Psychiatry (2007) 2.02
CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol (2011) 2.02
Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet (2011) 2.02
Change in depressive symptoms during the prodromal phase of Alzheimer disease. Arch Gen Psychiatry (2008) 1.98
Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. Arch Neurol (2006) 1.98
Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol (2010) 1.96
The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol (2002) 1.92